Study Code: GWCA0962; EudraCT Number: 2009-016065-29; A double blind, randomized, placebo-controlled, parallel group study of Sativex oromucosal spray (Sativex; Nabiximols) as adjunctive therapy in relieving uncontrolled persistent chronic pain in pati

Project: Research project

Project Details

StatusFinished
Effective start/end date4/24/12 → 4/23/15

Funding

  • GW Pharmaceuticals ( Award # ): $14,799.00